The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours
- PMID: 17762336
- DOI: 10.1097/JTO.0b013e31812f3c1a
The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours
Erratum in
- J Thorac Oncol. 2007 Oct;2(10):985
Abstract
Introduction: The seventh edition of the TNM Classification of Malignant Tumors is due to be published early in 2009. In preparation for this, the International Association for the Study of Lung Cancer established its Lung Cancer Staging Project in 1998. The recommendations of this committee for changes to the T, N, and M descriptors have been published. This report contains the proposals for the new stage groupings.
Methods: Data were contributed from 46 sources in more than 19 countries. Adequate data were available on 67,725 cases of non-small cell lung cancer treated by all modalities of care between 1990 and 2000. The recommendations for changes to the T, N, and M descriptors were incorporated into TNM subsets. Candidate stage groupings were developed on a training subset and tested in a validation subset.
Results: The suggestions include additional cutoffs for tumor size, with tumors >7 cm moving from T2 to T3; reassigning the category given to additional pulmonary nodules in some locations; and reclassifying pleural effusion as an M descriptor. In addition, it is suggested that T2b N0 M0 cases be moved from stage IB to stage IIA, T2a N1 M0 cases from stage IIB to stage IIA, and T4 N0-1 M0 cases from stage IIIB to stage IIIA.
Conclusions: Such changes, if accepted, will involve a reassessment of existing treatment algorithms. However, they are based on an intensive and validated analysis of the largest database to date. The proposed changes would improve the alignment of TNM stage with prognosis and, in certain subsets, with treatment.
Comment in
-
A seismic shift in staging.J Thorac Oncol. 2007 Aug;2(8):682-3. doi: 10.1097/JTO.0b013e318145af89. J Thorac Oncol. 2007. PMID: 17762332 No abstract available.
-
Adjuvant chemotherapy in new stage II pN0 non-small cell lung cancer: a new issue for a case-by-case decision making process.J Thorac Oncol. 2010 May;5(5):754. doi: 10.1097/JTO.0b013e3181d6bc50. J Thorac Oncol. 2010. PMID: 20421773 No abstract available.
-
European respiratory society/american thoracic society/international association for the study of lung cancer international multidisciplinary classification of lung adenocarcinoma: state of the art.J Thorac Oncol. 2011 Aug;6(8):1451. doi: 10.1097/JTO.0b013e318224643b. J Thorac Oncol. 2011. PMID: 21847068 No abstract available.
Similar articles
-
Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.Cancer J. 2010 Mar-Apr;16(2):176-81. doi: 10.1097/PPO.0b013e3181ce474e. Cancer J. 2010. PMID: 20404615
-
The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours.J Thorac Oncol. 2007 Aug;2(8):694-705. doi: 10.1097/JTO.0b013e31812d05d5. J Thorac Oncol. 2007. PMID: 17762335
-
The revised TNM staging system for lung cancer.Ann Thorac Cardiovasc Surg. 2009 Feb;15(1):4-9. Ann Thorac Cardiovasc Surg. 2009. PMID: 19262443 Review.
-
The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer.J Thorac Oncol. 2007 Jul;2(7):593-602. doi: 10.1097/JTO.0b013e31807a2f81. J Thorac Oncol. 2007. PMID: 17607114
-
[The IASLC lung cancer staging project. Comparing the current 6(th) TNM edition with the proposed 7(th) edition].Rev Port Pneumol. 2009 Jan-Feb;15(1):67-76. doi: 10.1016/s0873-2159(15)30110-0. Rev Port Pneumol. 2009. PMID: 19145388 Review. Portuguese.
Cited by
-
Use of new treatment modalities for non-small cell lung cancer care in the Medicare population.Chest. 2013 Feb 1;143(2):429-435. doi: 10.1378/chest.12-1149. Chest. 2013. PMID: 23187634 Free PMC article.
-
Pyroptosis-Related Gene Model Predicts Prognosis and Immune Microenvironment for Non-Small-Cell Lung Cancer.Oxid Med Cell Longev. 2022 Aug 31;2022:1749111. doi: 10.1155/2022/1749111. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36092153 Free PMC article.
-
[Variations in Serum CEA and CYFRA21-1 Levels Before and After Surgery Facilitate Prognosis of Non-small Cell Lung Cancer Patients].Zhongguo Fei Ai Za Zhi. 2015 Jun;18(6):358-64. doi: 10.3779/j.issn.1009-3419.2015.06.05. Zhongguo Fei Ai Za Zhi. 2015. PMID: 26104892 Free PMC article. Chinese.
-
Overexpression of a novel regulator of p120 catenin, NLBP, promotes lung adenocarcinoma proliferation.Cell Cycle. 2013 Aug 1;12(15):2443-53. doi: 10.4161/cc.25451. Epub 2013 Jun 28. Cell Cycle. 2013. PMID: 23839039 Free PMC article.
-
Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma.Oncotarget. 2017 Jan 24;8(4):7050-7058. doi: 10.18632/oncotarget.12540. Oncotarget. 2017. PMID: 27732964 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical